221 related articles for article (PubMed ID: 19639168)
1. Detection of metallothionein 1G as a methylated tumor suppressor gene in human hepatocellular carcinoma using a novel method of double combination array analysis.
Kanda M; Nomoto S; Okamura Y; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Int J Oncol; 2009 Sep; 35(3):477-83. PubMed ID: 19639168
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
[TBL] [Abstract][Full Text] [Related]
3. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
Hayashi M; Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Yamada S; Fujii T; Sugimoto H; Takeda S; Kodera Y
J Surg Oncol; 2012 Mar; 105(4):381-6. PubMed ID: 22052684
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma.
Kanda M; Nomoto S; Okamura Y; Hayashi M; Hishida M; Fujii T; Nishikawa Y; Sugimoto H; Takeda S; Nakao A
Mol Carcinog; 2011 Aug; 50(8):571-9. PubMed ID: 21268132
[TBL] [Abstract][Full Text] [Related]
5. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
6. MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma.
Ji XF; Fan YC; Gao S; Yang Y; Zhang JJ; Wang K
World J Gastroenterol; 2014 Apr; 20(16):4723-9. PubMed ID: 24782625
[TBL] [Abstract][Full Text] [Related]
7. Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis.
Inokawa Y; Nomoto S; Hishida M; Hayashi M; Kanda M; Nishikawa Y; Takeda S; Sugimoto H; Fujii T; Yamada S; Kodera Y
J Exp Clin Cancer Res; 2013 Sep; 32(1):65. PubMed ID: 24034596
[TBL] [Abstract][Full Text] [Related]
8. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
9. Protein tyrosine kinase 7: a hepatocellular carcinoma-related gene detected by triple-combination array.
Hishida M; Inokawa Y; Takano N; Nishikawa Y; Iwata N; Kanda M; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
J Surg Res; 2015 May; 195(2):444-53. PubMed ID: 25796105
[TBL] [Abstract][Full Text] [Related]
10. Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array.
Okamura Y; Nomoto S; Kanda M; Li Q; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
Cancer Lett; 2010 Mar; 289(2):170-7. PubMed ID: 19733004
[TBL] [Abstract][Full Text] [Related]
11. CCNJ detected by triple combination array analysis as a tumor-related gene of hepatocellular carcinoma.
Takano N; Hishida M; Inokawa Y; Hayashi M; Kanda M; Nishikawa Y; Iwata N; Kobayashi D; Tanaka C; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Kodera Y; Nomoto S
Int J Oncol; 2015 May; 46(5):1963-70. PubMed ID: 25672416
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor 1 gene as a tumor suppressor gene in hepatocellular carcinoma detected by triple-combination array analysis.
Hishida M; Nomoto S; Inokawa Y; Hayashi M; Kanda M; Okamura Y; Nishikawa Y; Tanaka C; Kobayashi D; Yamada S; Nakayama G; Fujii T; Sugimoto H; Koike M; Fujiwara M; Takeda S; Kodera Y
Int J Oncol; 2013 Jul; 43(1):88-94. PubMed ID: 23695389
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
[TBL] [Abstract][Full Text] [Related]
15. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma.
Liu Z; Ye Q; Wu L; Gao F; Xie H; Zhou L; Zheng S; Xu X
Mol Carcinog; 2018 Nov; 57(11):1435-1444. PubMed ID: 29873415
[TBL] [Abstract][Full Text] [Related]
17. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation.
Zekri Ael-R; Nassar AA; El-Din El-Rouby MN; Shousha HI; Barakat AB; El-Desouky ED; Zayed NA; Ahmed OS; El-Din Youssef AS; Kaseb AO; Abd El-Aziz AO; Bahnassy AA
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6721-6. PubMed ID: 24377595
[TBL] [Abstract][Full Text] [Related]
18. Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma.
Matsumura S; Imoto I; Kozaki K; Matsui T; Muramatsu T; Furuta M; Tanaka S; Sakamoto M; Arii S; Inazawa J
Clin Cancer Res; 2012 Jul; 18(13):3541-51. PubMed ID: 22573353
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
[TBL] [Abstract][Full Text] [Related]
20. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
